| Completed | Bioequivalence Study of Levetiracetam 1500 mg Coated Granules in Healthy, Male Subjects NCT07393022 | Desitin Arzneimittel GmbH | Phase 1 |
| Completed | A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Hea NCT07345130 | HALEON | Phase 1 |
| Not Yet Recruiting | Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions NCT06987773 | APR Applied Pharma Research s.a. | Phase 1 |
| Recruiting | Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast NCT07096869 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Phase 1 |
| Completed | A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different NCT06655194 | Bayer | Phase 1 |
| Not Yet Recruiting | Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants NCT06830954 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Coffee Bioequivalence Trial NCT06758531 | University of Reading | N/A |
| Completed | Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg NCT06331715 | Megalabs | Phase 4 |
| Unknown | Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions NCT06213610 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273 NCT06164431 | Guangdong Raynovent Biotech Co., Ltd | Phase 1 |
| Unknown | Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body NCT06066112 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Unknown | Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healt NCT06025214 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Unknown | Bioequivalence Study for Fluticasone Propionate 250 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healt NCT05982990 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and NCT06497049 | Geropharm | Phase 1 |
| Unknown | Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunt NCT05940909 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Und NCT05934799 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioequivalence of Amphotericin B Liposome for Injection NCT05913921 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Phase 1 |
| Completed | Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h) NCT05883124 | SocraTec R&D GmbH | Phase 1 |
| Completed | A Phase 1 Bioequivalence Study of Efgartigimod PH20 SC Administered Via a Prefilled Syringe Versus a Vial+Syri NCT05817435 | argenx | Phase 1 |
| Unknown | Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healt NCT05697003 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Table NCT06124547 | Galenicum Health | Phase 1 |
| Completed | Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Table NCT06124495 | Galenicum Health | Phase 1 |
| Completed | Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunt NCT05685277 | Pharmtechnology LLC | Phase 1 |
| Unknown | Bioequivalence Study of Sulfadoxine/ Pyrimethamine Dispersible Tablets in Healthy Subjects Under Fasting Condi NCT05497063 | Emzor Pharmaceutical Industries Limited | Phase 1 |
| Completed | Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under NCT05642845 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Table NCT06124573 | Galenicum Health | Phase 1 |
| Completed | Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Table NCT06124560 | Galenicum Health | Phase 1 |
| Completed | Bioequivalence of a Single-dose of 12 mg IVERMECTIN as Orally Disintegrating Mini Tablets Versus a Single-dose NCT05477810 | University Children's Hospital Basel | EARLY_Phase 1 |
| Completed | Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditi NCT05438316 | Pharmtechnology LLC | Phase 1 |
| Unknown | Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs G NCT05652595 | Geropharm | Phase 1 |
| Unknown | A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Part NCT05367388 | Apollomics Inc. | Phase 1 |
| Completed | Bioequivalence Study of Test and Reference 400 mg Ibuprofen Coated Tablets in Healthy Volunteers NCT05663398 | Darnitsa Pharmaceutical Company | Phase 1 |
| Unknown | A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmac NCT05397834 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Two Formulations of Tablets Aceclofenac 100 mg in Healthy Volunteers Under Fasting Con NCT05339373 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioavailability of Eszopiclone 3.0 mg With Regards to Reference Product NCT05349396 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product NCT05332106 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | Bioequivalence of Xaroban 20mg (Rivaroxaban) Tablet and Xarelto 20mg (Rivaroxaban) Tablet Under Fed Conditions NCT04689919 | University of Karachi | Phase 1 |
| Unknown | A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects NCT05297929 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Completed | Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product NCT05250141 | Laboratorios Andromaco S.A. | Phase 1 |
| Unknown | The Bioequivalence Study of Two Sunitinib Products in Capsules 50 mg in Healthy Volunteers Under Fasting Condi NCT05218616 | JLLC NatiVita | Phase 1 |
| Completed | Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers NCT05663372 | Darnitsa Pharmaceutical Company | Phase 1 |
| Completed | Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product NCT05158192 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product NCT05083325 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Condit NCT05061901 | Pharmtechnology LLC | Phase 1 |
| Unknown | Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respi NCT05085587 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Unknown | A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmac NCT05021887 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects NCT05519514 | Abbott | Phase 1 |
| Completed | Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Condit NCT04921566 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioequivalence Study of Esomeprazole in Healthy Adult Subjects Under Fasting Condition NCT05235217 | Future University in Egypt | Phase 1 |
| Completed | Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus NCT05470764 | Darnitsa Pharmaceutical Company | Phase 1 |
| Completed | Partially Replicate Bioequivalence Study of Quetiapine 25 mg in Healthy Volunteers Under Fasting Condition NCT05235230 | Future University in Egypt | Phase 1 |
| Completed | Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril NCT05464745 | Darnitsa Pharmaceutical Company | Phase 1 |
| Unknown | Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting NCT04882826 | Pharmtechnology LLC | Phase 1 |
| Completed | A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours NCT04889599 | Zhuhai Beihai Biotech Co., Ltd | Phase 3 |
| Unknown | Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Cond NCT04830579 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Feeding Conditions NCT04751318 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | Study to Assess the Bioequivalence of Acalabrutinib Tablet and Acalabrutinib Capsule NCT04768985 | AstraZeneca | Phase 1 |
| Completed | Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers NCT05014490 | Darnitsa Pharmaceutical Company | Phase 1 |
| Unknown | Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 10 mg in Healthy Male Volunteers in Fasting Co NCT04753489 | Pharmtechnology LLC | Phase 1 |
| Unknown | Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Con NCT04729998 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting Conditions NCT04723238 | Laboratorios Andromaco S.A. | Phase 1 |
| Unknown | A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powde NCT04746040 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product NCT04713904 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30 NCT06778304 | West China Second University Hospital | Phase 1 |
| Unknown | Bioequivalence Study of Sulfadoxine/ Pyrimethamine Tablets in Healthy Subjects Under Fasting Conditions NCT04577469 | Emzor Pharmaceutical Industries Limited | Phase 1 |
| Completed | Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product NCT04194905 | Laboratorios Andromaco S.A. | Phase 1 |
| Unknown | Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions NCT04651959 | Pharma Plant | Phase 1 |
| Completed | Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Prod NCT04230070 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg NCT05076474 | Shandong New Time Pharmaceutical Co., LTD | N/A |
| Completed | A Study of TEPEZZA Subcutaneous Administration in Healthy Adults NCT06563856 | Amgen | Phase 1 |
| Completed | A Pivotal Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalati NCT04564456 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Rosuvastatin in Healthy Volunteers Under Fasting Condition NCT05197517 | Rania Mahmoud Mohamed | Phase 1 |
| Completed | Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tab NCT04938856 | University of Karachi | Phase 1 |
| Completed | A Pilot Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation NCT04546256 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Oseltamivir Phosphate and TAMIFLU Under Fed Condition in Healthy Volunteers NCT04536415 | Austarpharma, LLC | Phase 4 |
| Completed | A Pilot Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation NCT04462822 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Unknown | A Bioequivalence Study to Compare Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subject NCT04527484 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Unknown | The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions NCT04476719 | Atabay Kimya Sanayi Ticaret A.S. | Phase 1 |
| Completed | A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalati NCT04466176 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions NCT04407000 | World Medicine ILAC SAN. ve TIC. A.S. | Phase 1 |
| Completed | Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions NCT04444986 | Kocak Farma | Phase 1 |
| Completed | A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects NCT04993222 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions NCT04400682 | Novelfarma Ilaç San. ve Tic. Ltd. Sti. | Phase 1 |
| Completed | Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions NCT04406194 | Atabay Kimya Sanayi Ticaret A.S. | Phase 1 |
| Completed | Randomized, Crossover Bioequivalence Study of PL-ASA Versus Immediate Release Aspirin in Healthy Volunteers. NCT05055752 | PLx Pharma | Phase 1 |
| Completed | An in Vivo Bioequivalence Study of 2 Loxoprofen Sodium Products in Vietnamese Healthy Male Volunteers NCT04386122 | Centre of Clinical Pharmacology, Hanoi Medical University | Phase 1 |
| Completed | Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting NCT04386876 | World Medicine ILAC SAN. ve TIC. A.S. | Phase 1 |
| Completed | Bioavailability of Clotiazepam 5 mg With Regards to Reference Product NCT04440423 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | Single Dose Crossover Comparative Bioavailability Study of Bupropion Hcl MR Tablet 300mg NCT05160090 | Alembic Pharmaceuticals Ltd. | Phase 1 |
| Completed | Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product NCT04422028 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | Bioavailability of Dienogest 2.0 mg With Regards to Reference Product NCT04230083 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fasting Conditions NCT04411940 | Cycle Pharmaceuticals Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fed Conditions NCT04411953 | Cycle Pharmaceuticals Ltd. | Phase 1 |
| Completed | Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product NCT04193852 | Laboratorios Andromaco S.A. | Phase 1 |
| Unknown | A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Sing NCT04138888 | Pharmtechnology LLC | Phase 1 |
| Withdrawn | Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate NCT03749733 | Grünenthal GmbH | Phase 1 |
| Completed | A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Char NCT04124094 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy A NCT04038008 | Pharmtechnology LLC | Phase 1 |
| Completed | The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Admin NCT04012307 | Pharmtechnology LLC | Phase 1 |
| Completed | A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection NCT04460820 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | N/A |
| Completed | Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions NCT04639869 | Humanis Saglık Anonim Sirketi | Phase 1 |
| Completed | Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia) NCT04268472 | Geropharm | N/A |
| Completed | Bioequivalence (BE) Study Comparing Fluconazole 150mg Capsule Manufactured in China and in France NCT03621072 | Pfizer | Phase 1 |
| Completed | A Bioequivalence Study Between Fluticasone Propionate 100 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powde NCT03975166 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Admini NCT03951051 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers NCT03918551 | Pharmtechnology LLC | Phase 1 |
| Completed | A Pharmacokinetic and Bioequivalence Study of Savolitinib Tablets in Healthy Chinese Male Volunteers NCT03860948 | Hutchison Medipharma Limited | Phase 1 |
| Completed | Pharmacokinetics of Metronidazole Dermal Products NCT03271983 | University of Maryland, Baltimore | EARLY_Phase 1 |
| Completed | Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxacin) Under Fasting Condition in NCT05307614 | Abbott | Phase 1 |
| Completed | Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers NCT03915340 | Pharmtechnology LLC | Phase 1 |
| Completed | A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. SERETIDE DISKUS® in Healthy Volunteers Wit NCT03894280 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Diflucan Bioequivalence Study For Transferring The Manufacture NCT03821480 | Pfizer | Phase 1 |
| Completed | A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powde NCT03820180 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 m NCT03799536 | Pharmtechnology LLC | Phase 1 |
| Completed | Study to Assess Bioequivalence of a New Nifurtimox Oral Tablet Formulation NCT03708133 | Bayer | Phase 1 |
| Completed | A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers NCT03751202 | Respirent Pharmaceuticals Co Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augm NCT03702894 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fastin NCT03705533 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioequivalence of Imeglimin Tablet Formulations NCT03646331 | Poxel SA | Phase 1 |
| Completed | Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h) NCT03659435 | SocraTec R&D GmbH | Phase 1 |
| Completed | Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Bela NCT03616301 | Pharmtechnology LLC | Phase 1 |
| Completed | Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In H NCT04101370 | Geropharm | Phase 1 |
| Completed | Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase NCT03573050 | SocraTec R&D GmbH | Phase 1 |
| Completed | A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Su NCT03557580 | Qilu Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Vo NCT05549583 | Galenicum Health | Phase 1 |
| Completed | Bioequivalence Study of Clopid® (Clopidogrel) 75 mg Tablet and Plavix® 75 mg Tablet After Oral Administration NCT05186129 | Center for Bioequivalence Studies and Clinical Research | Phase 1 |
| Completed | A Study Comparing Oxymetazoline 1% Cream to RHOFADE NCT05148689 | Sun Pharmaceutical Industries, Inc. | Phase 1 |
| Completed | Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp NCT06050343 | Geropharm | N/A |
| Completed | A Pilot Bioequivalence Study of Pomalidomide NCT03424928 | Jiangsu Simcere Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Comparative Bioavailability Study of Lamotrigine ER Tablets USP 50 mg NCT05145608 | Alembic Pharmaceuticals Ltd. | Phase 1 |
| Completed | Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States NCT03353480 | Pfizer | Phase 1 |
| Completed | Pharmacokinetics and Pharmacodynamics of CinnoVex (Interferon Beta-1a) Compared to Avonex (Interferon Beta-1a) NCT03614715 | Cinnagen | Phase 1 |
| Unknown | Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone Tablets NCT03420534 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 |
| Completed | Bioavailability of ATI-1501 With Taste Test Sub Study NCT03337126 | Appili Therapeutics Inc. | Phase 1 |
| Completed | Bioavailability of KBP-5074 Tablet vs Capsule Formulations NCT03340753 | KBP Biosciences | Phase 1 |
| Completed | Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russ NCT04501250 | Geropharm | N/A |
| Completed | Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Vol NCT05549570 | Galenicum Health | Phase 1 |
| Completed | Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, NCT04498884 | Geropharm | N/A |
| Completed | A Bioequivalence Study Between Two Brands of Medications to Treat Cough & Cold Symptoms NCT03213353 | Johnson & Johnson Consumer and Personal Products Worldwide | Phase 1 |
| Unknown | Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition NCT03232710 | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | N/A |
| Completed | Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Health NCT03452306 | Geropharm | Phase 1 |
| Completed | Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta NCT03146988 | Gedeon Richter Plc. | Phase 1 |
| Completed | Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR NCT03458208 | Geropharm | Phase 1 |
| Completed | Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers NCT02974439 | Shanghai Haini Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects NCT03273088 | AryoGen Pharmed Co. | Phase 1 |
| Completed | Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers NCT02341274 | Indiana University | Phase 1 |
| Completed | A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects NCT03273192 | Cinnagen | Phase 1 |
| Completed | Ibuprofen Bioavailability Trial With Oral Single Dose Administration. NCT03018015 | SocraTec R&D GmbH | Phase 1 |
| Withdrawn | Bioequivalence Study of Idalopirdine in Healthy Subjects NCT02894515 | H. Lundbeck A/S | Phase 1 |
| Completed | Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral NCT02980458 | SocraTec R&D GmbH | Phase 1 |
| Completed | A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy S NCT02637037 | AstraZeneca | Phase 1 |
| Completed | Oral Bio-equivalence Study NCT05145621 | Alembic Pharmaceuticals Ltd. | Phase 1 |
| Completed | Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release NCT02436577 | AstraZeneca | Phase 1 |
| Completed | Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With N NCT02385851 | Coherus Oncology, Inc. | Phase 1 |
| Completed | Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of C NCT02221180 | Janssen Research & Development, LLC | Phase 1 |
| Completed | Comparison of Two Formulations of Androxal NCT01984398 | Repros Therapeutics Inc. | Phase 1 |
| Completed | Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablet NCT02206295 | Actelion | Phase 1 |
| Completed | Clinical Study to Evaluate the Role of Microdialysis for the Comparison of Topical Products NCT01592019 | University of Florida | EARLY_Phase 1 |
| Completed | A Bioequivalence Study to Compare VIMOVO Manufactured at AstraZenca AB to VIMOVO Manufactured by Patheon Pharm NCT01331993 | AstraZeneca | Phase 1 |
| Completed | Bio-equivalence Study NCT01638143 | Maastricht University Medical Center | N/A |
| Completed | A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers. NCT01260805 | Pfizer | Phase 1 |
| Completed | Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine NCT01094847 | Daewoong Pharmaceutical Co. LTD. | Phase 1 |
| Completed | Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women NCT02592031 | Merckle GmbH | Phase 1 |
| Completed | Bioavailability Of A Single Dose Of Nifedipine Oral Solution Compared To Adalat Capsules In Healthy Female Vol NCT02071589 | Reig Jofre Group | Phase 1 |
| Completed | Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex NCT04008979 | PLx Pharma | Phase 1 |
| Completed | Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions NCT01340625 | Teva Pharmaceuticals USA | Phase 1 |
| Completed | A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System NCT00614029 | Zogenix, Inc. | Phase 1 |